法国学者Montalescot等研究发现,与300mg负荷量相比,口服更大负荷剂量(600mg或900mg)氯吡格雷有更好的抑制血小板凝集(IPA)作用。作者选择了103例非ST段抬高的急性冠状动脉综合征(NSTEACS)患者,在包括阿司匹林在内的常规治疗基础上,将其随机分3组,分别口服300mg、600mg和900mg? A study by French scholar Montalescot et al. Found that clopidogrel administered at a greater loading dose (600 mg or 900 mg) had better inhibition of platelet aggregation (IPA) than the 300 mg dose. The authors selected 103 patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) who were randomized to receive either 300 mg, 600 mg, or 900 mg, respectively, on a routine basis, including aspirin.